Amphastar Pharmaceuticals Inc header image

Amphastar Pharmaceuticals Inc

AMPH

Equity

ISIN null / Valor 24511852

NASDAQ (2026-06-25)
USD 21.04+0.10%

Amphastar Pharmaceuticals Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), headquartered in Rancho Cucamonga, California, is a specialty pharmaceutical company that develops, manufactures and commercializes injectable, inhalation and other dosage-form medicines for hospital, emergency medicine and consumer markets. The company sells a mix of marketed branded and generic products, provides contract manufacturing services and operates its own production facilities to supply finished-dosage forms and drug-device combinations to wholesalers, distributors and government purchasers in the United States and abroad. Amphastar’s business is driven by sales of established products and ongoing regulatory filings and product development efforts to expand its pipeline of approved drug products and abbreviated new drug applications.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-10.3%1Y
-63.2%3Y
0.57%5Y

Performance

56.1%1Y
47.2%3Y
46.0%5Y

Volatility

Market cap

928 M

Market cap (USD)

Daily traded volume (Shares)

481,265

Daily traded volume (Shares)

1 day high/low

37.69 / 36.83

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%USD 24.73
Corcept Therapeutics Inc
Corcept Therapeutics Inc Corcept Therapeutics Inc Valor: 1812837
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.91%USD 84.75
Unitedhealth Group Inc
Unitedhealth Group Inc Unitedhealth Group Inc Valor: 1078451
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.40%USD 415.53
BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.48%USD 69.69
GSK PLC
GSK PLC GSK PLC Valor: 120042705
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.57%USD 51.89
Eris Lifesciences Ltd
Eris Lifesciences Ltd Eris Lifesciences Ltd Valor: 37115190
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.45%INR 1,458.80
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd Max Healthcare Institute Ltd Valor: 45624817
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.86%INR 1,122.85
Interparfums
Interparfums Interparfums Valor: 86977
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.08%EUR 25.45
Evolva Holding LTD
Evolva Holding LTD Evolva Holding LTD Valor: 126205578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
19.68%CHF 2.21
Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A. Valor: 2791431
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.97%CHF 12.61